BMS-986454
/ BMS
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
September 16, 2025
A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis
(clinicaltrials.gov)
- P1 | N=46 | Not yet recruiting | Sponsor: Bristol-Myers Squibb
New P1 trial • Immunology • Inflammatory Arthritis • Rheumatoid Arthritis • Rheumatology
March 24, 2025
A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986454 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=63 | Completed | Sponsor: Bristol-Myers Squibb | Active, not recruiting ➔ Completed | Trial completion date: Mar 2026 ➔ Dec 2024 | Trial primary completion date: Mar 2026 ➔ Dec 2024
Trial completion • Trial completion date • Trial primary completion date
January 29, 2025
A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986454 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=56 | Active, not recruiting | Sponsor: Bristol-Myers Squibb | Recruiting ➔ Active, not recruiting | Trial completion date: Dec 2024 ➔ Mar 2026 | Trial primary completion date: Dec 2024 ➔ Mar 2026
Enrollment closed • Trial completion date • Trial primary completion date
1 to 3
Of
3
Go to page
1